Jay Lichter
Vorsitzender bei JANUX THERAPEUTICS, INC.
Vermögen: 215 859 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Jay Lichter
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Illinois
581
| College/University | Other Consumer Services | 581 |
40
| Private Company | Biotechnology | 40 |
University of Illinois At Urbana–Champaign
35
| College/University | Other Consumer Services | 35 |
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Public Company | Biotechnology | 19 | |
Avalon Ventures Management LLC
 Avalon Ventures Management LLC Investment ManagersFinance Avalon Ventures Management LLC (Avalon Ventures Management) is a venture capital firm founded in 1983 by Kevin J. Kinsella. The firm is headquartered in La Jolla, California.
13
| Private Company | Investment Managers | 13 |
John Wayne Cancer Institute
 John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients.
9
| Private Company | Miscellaneous Commercial Services | 9 |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA.
8
| Holding Company | Medical/Nursing Services | 8 |
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Enlaza Therapeutics, Inc.
 Enlaza Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enlaza Therapeutics, Inc. is a company that develops novel classes of protein therapeutics using their proprietary war-lock™ platform. The company is based in La Jolla, CA. The company's platform utilizes synthetic biology technology for site-specific covalent coupling driven by drug binding. Enlaza Therapeutics is pioneering the field of covalent biologics and is building a pipeline of first-in-class covalent biologics. The CEO of the company is Sergio G. Duron.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Nerio Therapeutics, Inc.
 Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Cullinan Mica Corp.
 Cullinan Mica Corp. Pharmaceuticals: MajorHealth Technology Part of Cullinan Therapeutics, Inc., Cullinan Mica Corp. is a company that provides worldwide rights to CLN-619. The company is based in Cambridge, MA. The CEO of the company is Nadim Ahmed.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Carolus Therapeutics, Inc.
 Carolus Therapeutics, Inc. BiotechnologyHealth Technology Carolus Therapeutics, Inc. develops novel products for the treatment of inflammatory diseases. It company focuses on therapeutic strategies to noninvasively monitor and disrupt proinflammatory interactions of chemokines, and prevent or reverse inflammation associated with an array of human diseases, including atherosclerosis, rheumatoid arthritis, multiple sclerosis, sepsis, organ transplantation, and cancer. The company was founded by Jay Lichter, Jürgen Bernhagen, and Christian Weber in 2007 and is headquartered in San Diego, CA.
2
| Holding Company | Biotechnology | 2 |
Pacific Ridge School
 Pacific Ridge School Other Consumer ServicesConsumer Services Pacific Ridge School operates a school. The non-profit company is based in Carlsbad, CA.
2
| Non-Profit Organization | Other Consumer Services | 2 |
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology COI Pharmaceuticals, Inc. provides life science investors. It offers research and development infrastructure and industry mentors to the portfolio companies of Avalon Ventures. The company was founded in 2013 and is headquartered in La Jolla, CA.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Silarus Therapeutics, Inc.
 Silarus Therapeutics, Inc. BiotechnologyHealth Technology Silarus Therapeutics, Inc. develops therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. The company was founded by Tomas Ganz, Sanford J. Madigan, and Elizabeta Nemeth in May 19, 2014 and is headquartered in La Jolla, CA.
2
| Holding Company | Biotechnology | 2 |
Cellular Approaches, Inc.
 Cellular Approaches, Inc. BiotechnologyHealth Technology Cellular Approaches, Inc. operates in the biotechnology industry. It develops pipeline of innate immunity cell-based therapeutics for the treatment of infectious disease, autoimmunity, neurodegeneration and aging. The company was founded in 2016 and is headquartered in La Jolla, CA.
2
| Private Company | Biotechnology | 2 |
Fortis Therapeutics, Inc.
 Fortis Therapeutics, Inc. BiotechnologyHealth Technology Fortis Therapeutics, Inc. operates as a immuno-oncology biotech company. It focuses on developing new antibody drug conjugate therapies for late-stage multiple myeloma and late-stage prostate cancer. The company is headquartered in La Jolla, CA.
1
| Holding Company | Biotechnology | 1 |
ReVision Therapeutics, Inc.
 ReVision Therapeutics, Inc. Drugstore ChainsRetail Trade ReVision Therapeutics, Inc. develops drugs for the treatment of age-related macular degeneration diseases. The firm operates as a ophthalmic biopharmaceutical company. Its products include Fenretinide, an oral medication that reduces the accumulation of A2E in the retina, and slows down the growth of atrophic lesions, which precedes vision loss. The company was founded in April 2010 and is headquartered in La Jolla, CA.
1
| Extinct | Drugstore Chains | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jay Lichter
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Biotechnology | Founder Corporate Officer/Principal Corporate Officer/Principal | |
DJO Global, Inc.
 DJO Global, Inc. Medical SpecialtiesHealth Technology DJO Global, Inc. engages in the development and distribution medical devices for musculoskeletal health, joint reconstruction, vascular health, and pain management. Its product include knee ligament bracing, custom bracing, post-op knee bracing, hip implants, shoulder implants, shoulder bracing, spine bracing, cervical collars, walking braces, and ankle bracing. The company was founded by Mark Nordquist and Ken Reed in 1978 and is headquartered in Lewisville, TX. | Medical Specialties | Director of Finance/CFO Comptroller/Controller/Auditor | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Founder General Counsel Chairman Director/Board Member | |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Afraxis, Inc. operates as a contract research organization (CRO), specializes in preclinical efficacy evaluations (in vivo and in vitro), neurotoxicity evaluations, and structure-efficacy relationship (SER)-driven medicinal chemistry. It develops Afraxis ESP, an enhanced spine analysis platform that quantifies the morphology and maturity of synaptic dendritic spines, which are fundamental to information processing by neural synapses in the brain. The company was founded by Jay B. Lichter, Carmine Stengone, Susumu Tonegawa and Ben Vollrath in 2007 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Founder | |
RQx Pharmaceuticals, Inc.
 RQx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RQx Pharmaceuticals, Inc. operates as a biopharmaceutical company developing small molecule antibiotics. The firm develops small molecule antibiotics to combat serious life threatening infections, including those caused by multi drug-resistant Gram-negative bacteria. It is developing novel, first-in-class antibiotics that evade the current abundance of antibiotic resistance mechanisms, which are now common across the globe. The company was founded in 2010 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Compliance Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
| University of California, Los Angeles | College/University | Undergraduate Degree Director/Board Member Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| San Diego State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
| Colgate University | College/University | Comptroller/Controller/Auditor Undergraduate Degree | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
| Princeton University | College/University | Director/Board Member Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Graduate Degree | |
| National Taiwan University | College/University | Undergraduate Degree Undergraduate Degree | |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The company is based in Washington. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| St. John's Health Center Foundation | Director/Board Member Director/Board Member | ||
| Kansas City Area Life Sciences Institute, Inc. | Director/Board Member Director/Board Member | ||
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of San Diego School of Law | College/University | Graduate Degree Graduate Degree | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
JUMPCODE Genomics, Inc.
 JUMPCODE Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Jumpcode Genomics, Inc. provides healthcare services. The company is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
ImmunOs Therapeutics AG
 ImmunOs Therapeutics AG BiotechnologyHealth Technology ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith. | Biotechnology | Director/Board Member Director/Board Member | |
Adanate, Inc.
 Adanate, Inc. BiotechnologyHealth Technology Adanate, Inc. develops antibody therapeutics. The CEO of the American company is Chris Griffith. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Medikine, Inc.
 Medikine, Inc. Pharmaceuticals: MajorHealth Technology Medikine, Inc. is a privately held biopharmaceutical company located in an undisclosed location. The American company's mission is to transform the discovery of oncology, autoimmune disorder, and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular "peptikines." These peptikines are peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate. Medikine's lead candidate, mdk-703, is currently in a phase 1 clinical trial in healthy volunteers. Ronald W. Barrett has been the CEO of the company since 2016. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Anexigen, Inc.
 Anexigen, Inc. BiotechnologyHealth Technology Anexigen, Inc. is a biotechnology company developing novel methods and compositions to combat existing and burgeoning antimicrobial threats. The company was founded by Sanford Madigan and Sergio Duron and is headquartered in La Jolla, CA. | Biotechnology | Founder Chief Executive Officer | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO |
Statistik
International
| Vereinigte Staaten | 47 |
| Vereinigtes Königreich | 2 |
| Taiwan | 2 |
| Belgien | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 18 |
| Commercial Services | 7 |
| Finance | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 514 |
| Corporate Officer/Principal | 231 |
| Independent Dir/Board Member | 124 |
| Undergraduate Degree | 90 |
| Founder | 73 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Topper | 49 |
| Kevin Kinsella | 34 |
| Gary Pace | 32 |
| Shelley Chu | 31 |
| Peter Bisgaard | 28 |
| Vickie Capps | 27 |
| Steven St. Peter | 26 |
| Anthony Adam Rosenberg | 23 |
| Craig Tooman | 22 |
| Robert Gerber | 21 |
| William P. Rutledge | 20 |
| Neil Gibson | 20 |
| Irvine O. Hockaday | 20 |
| Kirk Malloy | 20 |
| Julia S. Gouw | 20 |
- Börse
- Insiders
- Jay Lichter
- Unternehmensverbindungen
